Cargando…
Combination of Immune Checkpoint Inhibitors and Radiotherapy for Advanced Non-Small-Cell Lung Cancer and Prostate Cancer: A Meta-Analysis
OBJECTIVES: Immune checkpoint inhibitors (ICI) combined with radiotherapy (RT) have emerged as a breakthrough therapy in the treatment of various cancers. The combination has a strong rationale, but data on their efficacy and safety are still limited. Hence, we comprehensively searched the database...
Autores principales: | Xu, Zexi, Feng, Jia, Weng, Yiming, Jin, Yao, Peng, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803407/ https://www.ncbi.nlm.nih.gov/pubmed/33488711 http://dx.doi.org/10.1155/2021/6631643 |
Ejemplares similares
-
Radiotherapy plus immune checkpoint inhibitor in prostate cancer
por: Li, Tianjie, et al.
Publicado: (2023) -
The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer
por: Wei, Jiayan, et al.
Publicado: (2021) -
Beyond Abscopal Effect: A Meta-Analysis of Immune Checkpoint Inhibitors and Radiotherapy in Advanced Non-Small Cell Lung Cancer
por: Fiorica, Francesco, et al.
Publicado: (2021) -
Combined Treatment with Ultrasound and Immune Checkpoint Inhibitors for Prostate Cancer
por: Hayashi, Fuuka, et al.
Publicado: (2022) -
Immune Checkpoint Inhibitors in Prostate Cancer
por: Venkatachalam, Shobi, et al.
Publicado: (2021)